- Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
-
Chong SL, Ahmad Asnawi AW, Leong TS, Tan JT, Law KB, Hon SL, Fann RJ, Tan SM
- KMID: 2520611
- Blood Res.
- 2021 Sep;56(3):175-183.
- doi: 10.5045/br.2021.2021045
Background With the emergence of tyrosine kinase inhibitors and the incorporation of stringent measurable residual disease (MRD) monitoring, risk stratification for BCR-ABL1-positive acute lymphoblastic leukemia (ALL) patients has changed significantly. However,... -
- CITED
-
- Close
- SHARE
-
- Close
